Fuwai Hospital
Beijing, Beijing Municipality, 100037, China
NCT Number: NCT05645640
The China PEACE SMARTER trial is a cluster ramdomized trial aiming to assess the effectiveness of village doctor-led tailored health management on risk reduction of high-risk individuals for cardiovascular disease.
Looking for future studies?
Notify Me35 year and older
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100037, China
In this study, investigators aim to develop a series of intervention strategies for cardiovascular disease (CVD) prevention through village doctor-led tailored health management in individuals with elevated risk, then assess their effectiveness through a cluster randomized trial. Investigators hypothesize that the village doctor-led tailored health management can reduce the CVD risk and improve risk factor control of the high-risk subjects through 12 months of follow-up. Around 4200 subjects from 120 villages in mainland China who are considered to be eligible according to inclusion and exclusion criteria will be enrolled to the study. The eligibility criteria is: Individuals aged 35 or above who are in high risk for CVD (10-year ASCVD risk ≥10%), able to use smart phone, and contracted with the local family doctor. Patients with history of CVD or severe illnesses, pregnancy, cognition or communication problems are excluded from the study. The selected villages will be assigned (1:1) to either control group (usual care) or intervention group (village doctor-led tailored health management). The primary outcome is the change in 10-year ASCVD risk from baseline to 12 months. Follow up visits will be conducted every 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigators will "sketch" features of cardiovascular risk factor combinations for the high-risk subjects and accordingly set tailored promotion targets for them. Subjects will receive individualized consultation about their cardiovascular risk profile and tailored health management led by village doctors. They will receive tailored health text messages pushed by village doctors 3 times a week, including contents in physical activity, healthy diet, smoking abstinence, responsible alcohol drinking, sleep, and medication adherence. They will be provided with a smart band, and supposed to daily wear the smart band to collect health data. The progress of tailored promotion targets will be evaluated every 3 months, and feedback will be given in the form of virtual rewards and punishments: completed (a virtual golden egg) and failed (a virtual bomb). According to the number of virtual golden eggs, participants could redeem project gift in real life.
Time frame: 12 months
Changes in 10-year ASCVD risk score from baseline to 12 months
Time frame: 12 months
Changes in lifetime ASCVD risk score from baseline to 12 months
Time frame: 12 months
Changes in systolic and diastolic blood pressure from baseline to 12 months
Time frame: 12 months
Changes in fasting plasma glucose (FPG) from baseline to 12 months
Time frame: 12 months
Changes in Non-HDL cholesterol from baseline to 12 months
Time frame: 12 months
Changes in proportion of subjects who are overweight and obesity from baseline to 12 months
Time frame: 12 months
Changes in proportion of daily smoking persons from baseline to 12 months
Time frame: 12 months
Changes in proportion of subjects with insufficient physical activity (<3000 MET min/wk) from baseline to 12 months
Time frame: 12 months
Changes in proportion of subjects who report taking the full dose of prescribed medications ≥6 days per week among all necessary subjects from baseline to 12 months
Time frame: 12 months
Major adverse cardiovascular events, including occurrence of death, myocardial infarction, stroke, and cardiovascular hospitalization
China National Center for Cardiovascular Diseases
Other Gov
China Patient-centered Evaluative Assessment of Cardiac Events (PEACE): Strategy for Cardiovascular Disease Prevention Through Tailored Health Management and Its Effectiveness Assessment Through a Cluster Randomized Trial in Individuals With Elevated Risk (SMARTER)
Acronym: SMARTER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00128687
Behavior, Cardiovascular Diseases
View Trial DetailsNCT04891575
Behavior, Cardiovascular Diseases
Lexington, Kentucky, United States
View Trial DetailsNCT04166643
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT05915455
Behavior, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial Details